ALS (CPBLF) vs. Its Rivals Head to Head Contrast

ALS (OTCMKTS:CPBLF) is one of 205 publicly-traded companies in the “Professional Services” industry, but how does it contrast to its competitors? We will compare ALS to similar businesses based on the strength of its valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and earnings.

Valuation and Earnings

This table compares ALS and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
ALS	N/A	N/A	54.57
ALS Competitors	$3.31 billion	$226.41 million	32.47

ALS’s competitors have higher revenue and earnings than ALS. ALS is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Dividends

ALS pays an annual dividend of $0.39 per share and has a dividend yield of 2.5%. ALS pays out 134.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Professional Services” companies pay a dividend yield of 2.7% and pay out -158.6% of their earnings in the form of a dividend. ALS lags its competitors as a dividend stock, given its lower dividend yield and higher payout ratio.

Profitability

This table compares ALS and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ALS	N/A	N/A	N/A
ALS Competitors	1.36%	19.13%	4.65%

Insider & Institutional Ownership

23.2% of ALS shares are held by institutional investors. Comparatively, 57.3% of shares of all “Professional Services” companies are held by institutional investors. 17.0% of shares of all “Professional Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings for ALS and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ALS	0	0	1	0	3.00
ALS Competitors	1475	6292	9050	477	2.49

ALS presently has a consensus target price of $28.00, suggesting a potential upside of 77.50%. As a group, “Professional Services” companies have a potential upside of 36.44%. Given ALS’s stronger consensus rating and higher probable upside, equities research analysts plainly believe ALS is more favorable than its competitors.

Summary

ALS competitors beat ALS on 9 of the 13 factors compared.

ALS Company Profile

ALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, and the Americas. It operates in two segments, Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides coal sampling, analysis and certification, formation evaluation, and related analytical testing services. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment provides analytical testing data to assist consulting and engineering firms, industries, and governments. ALS Limited was founded in 1863 and is headquartered in Brisbane, Australia.